Sign In
Buy CTLT
$63.49
+0 (+0%)
At Close: Mar 14, 2025
Catalent stock rockets 21% premarket on report of takeover interest from Danaher
06:35am, Monday, 06'th Feb 2023
Life Sciences Company Danaher Corp. DHR, -0.31% is interested in taking over contract manufacturer Catalent Inc. CTLT, -1.04% and is willing to pay a significant premium for the company, Bloomberg rep
Danaher interested in buying life sciences firm Catalent- Bloomberg News
02:27pm, Saturday, 04'th Feb 2023
Medical equipment maker Danaher Corp has expressed interest in taking over contract drugmaker Catalent Inc , Bloomberg News reported on Saturday, citing people familiar with the matter.
Catalent (CTLT) to Report Q2 Earnings: What's in the Cards?
03:29pm, Friday, 03'rd Feb 2023 Zacks Investment Research
Catalent's (CTLT) Q2 results are likely to have been driven by robust segmental performances.
Catalent (CTLT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
03:00pm, Tuesday, 31'st Jan 2023 Zacks Investment Research
Catalent (CTLT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates
11:55pm, Tuesday, 24'th Jan 2023 Zacks Investment Research
Taro (TARO) delivered earnings and revenue surprises of -78.16% and 14.66%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Analyst Ratings for Catalent
08:00pm, Tuesday, 24'th Jan 2023 Benzinga
Analysts have provided the following ratings for Catalent (NYSE:CTLT) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
5
1
0
0
Last 30D
Barclays Maintains Overweight Rating for Catalent: Here's What You Need To Know
05:00pm, Tuesday, 24'th Jan 2023 Benzinga
Barclays has decided to maintain its Overweight rating of Catalent (NYSE:CTLT) and lower its price target from $62.00 to $58.00.
Shares of Catalent are trading down 3.19% over the last 24 hours, at $5
The Market's 10 Worst Stocks Are Now First
08:00am, Monday, 23'rd Jan 2023
Remember all the beat-up stocks investors wrote off last year? In an interesting twist, last year's worst stocks are turning into the first.
Catalent, Inc. Announces Second Quarter Fiscal Year 2023 Earnings Conference Webcast
08:38am, Friday, 20'th Jan 2023
SOMERSET, N.J.--( BUSINESS WIRE )--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patien
Catalent's (CTLT) New Deal to Utilize Its Zydis ODT Technology
04:37pm, Monday, 16'th Jan 2023 Zacks Investment Research
Catalent's (CTLT) latest development and license agreement is expected to accelerate the administration of therapeutic doses of active drugs.
Catalent's (CTLT) New Deal to Utilize Its Zydis ODT Technology
12:47pm, Monday, 16'th Jan 2023
Catalent's (CTLT) latest development and license agreement is expected to accelerate the administration of therapeutic doses of active drugs.
Catalent: Starting Valuations, ROIC Supportive, Rate Buy
07:03am, Friday, 06'th Jan 2023
Investors were net sellers of Catalent equity across the back end of 2022. Much of the downside is explained by diminishing Covid-19 revenues and potential near-term challenges to earnings quality.
Catalent, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
05:15pm, Tuesday, 03'rd Jan 2023
SOMERSET, N.J.--( BUSINESS WIRE )--Catalent, Inc. (NYSE: CTLT), the global leader in enabling pharma, biotech, and consumer health partners to optimize development, launch, and supply of better patien
These 20 stocks were the biggest losers of 2022
01:16pm, Saturday, 31'st Dec 2022 MarketWatch
Valuations for the most expensive big tech stocks finally fell to more reasonable levels.
Analysts Pound The Table For 11 Stocks Trading For 50% Off
08:00am, Thursday, 29'th Dec 2022
Savvy investors know to stick with stocks in an uptrend. But analysts are still pounding the table for some S&P 500 stocks.
